Founded Year

2015

Stage

Unattributed - II | Alive

Total Raised

$50.57M

Valuation

$0000 

Last Raised

$40.27M | 1 yr ago

About IntraBio

IntraBio operates as a biopharmaceutical company focused on the research, development, and commercialization of therapies for rare and neurodegenerative diseases. The company's main offerings include clinical trials and development programs for treatments that address conditions with high unmet medical needs. IntraBio primarily serves the healthcare sector, particularly in areas related to neurodegeneration and rare disease treatment. It was founded in 2015 and is based in Austin, Texas.

Headquarters Location

201 West 5th Street Suite 1100

Austin, Texas, 78701,

United States

8770 386-7402

Loading...

Loading...

Expert Collections containing IntraBio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

IntraBio is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,276 items

IntraBio Patents

IntraBio has filed 22 patents.

The 3 most popular patent topics include:

  • rare diseases
  • autosomal recessive disorders
  • neurological disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/11/2017

11/19/2024

Rare diseases, Autosomal recessive disorders, Neurological disorders, Neurodegenerative disorders, Syndromes

Grant

Application Date

8/11/2017

Grant Date

11/19/2024

Title

Related Topics

Rare diseases, Autosomal recessive disorders, Neurological disorders, Neurodegenerative disorders, Syndromes

Status

Grant

Latest IntraBio News

IntraBio Inc. Completes Recruitment for IB1001 A-T Pivotal Clinical Trial

Jul 1, 2025

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. announced today that it has completed recruitment for its Phase III Pivotal Trial “IB1001-303”, Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A randomized, placebo-controlled, double-blind, crossover study (NCT06673056). Enrollment for the Phase III trial commenced in May 2025 and was conducted across ten multinational trial sites in Germany, Slovakia, Spain, Switzerland, the United Kingdom, and the United States. After four weeks, 1

IntraBio Frequently Asked Questions (FAQ)

  • When was IntraBio founded?

    IntraBio was founded in 2015.

  • Where is IntraBio's headquarters?

    IntraBio's headquarters is located at 201 West 5th Street, Austin.

  • What is IntraBio's latest funding round?

    IntraBio's latest funding round is Unattributed - II.

  • How much did IntraBio raise?

    IntraBio raised a total of $50.57M.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.